Renaissance Technologies
IMNP

Renaissance Technologies’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

Renaissance Technologies’s Portfolio IMNP Stock Details IMNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-138,205
Closed -$26K – 3698
2018
Q2 		$26K Buy
+138,205
New +$39.1K ﹤0.01% 3210
2016
Q4 		– Sell
-7,625
Closed -$43K – 3606
2016
Q3 		$43K Buy
+7,625
New +$56.3K ﹤0.01% 3263

Other funds holding IMNP

IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return

Renaissance Technologies's IMNP Position: Q3 2018 in Review

Renaissance Technologies sold out of Immune Pharmaceuticals Inc. (IMNP) in Q3 2018, closing a stake of 138,205 shares — an estimated $26K sold.

Renaissance Technologies first reported a position in IMNP in Q3 2016 and held it in 2 quarters. The position peaked at $43K in Q3 2016. 1 fund tracked by Wall St. Rank holds IMNP as of Q3 2018.

  • Renaissance Technologies reported no remaining Immune Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Renaissance Technologies sold 138,205 Immune Pharmaceuticals Inc. shares in Q3 2018, an estimated $26K.
  • Renaissance Technologies first reported a position in Immune Pharmaceuticals Inc. in Q3 2016 and held it in 2 quarters.
  • Renaissance Technologies's Immune Pharmaceuticals Inc. position peaked at $43K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q3 2018.

Based on Renaissance Technologies's 13F filing for Q3 2018, filed 13 Nov 2018.